Cercano Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$126M Sell
137,377
-5,077
-4% -$5.15M 5.46% 5
2025
Q4
$153M Sell
142,454
-6,933
-5% -$6.63M 5.79% 5
2025
Q3
$114M Sell
149,387
-24,396
-14% -$18.2M 4.37% 6
2025
Q2
$135M Buy
173,783
+172,678
+15,627% +$134M 3.87% 8
2025
Q1
$913K Hold
1,105
0.03% 89
2024
Q4
$853K Hold
1,105
0.02% 116
2024
Q3
$979K Buy
+1,105
New +$993K 0.02% 96

Other funds holding LLY

Cercano Management's LLY Position: Q1 2026 in Review

Cercano Management reduced its Eli Lilly (LLY) stake by 3.6% in Q1 2026, selling an estimated $5.15M and leaving 137,377 shares worth $126M. The position accounts for 5.46% of the portfolio, ranked #5.

Cercano Management first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $153M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cercano Management held 137,377 shares of Eli Lilly worth $126M as of Q1 2026.
  • Cercano Management sold 5,077 Eli Lilly shares in Q1 2026, an estimated $5.15M.
  • Eli Lilly made up 5.46% of Cercano Management's portfolio in Q1 2026, its #5 holding.
  • Cercano Management first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Cercano Management's Eli Lilly position peaked at $153M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cercano Management's 13F filing for Q1 2026, filed 13 May 2026.